Immunohistochemical analysis of expression of a 65 kDa oncofetal protein (p65), epidermal growth factor receptor (EGFR), oncogene c-erb B2 and tumor suppressor gene p53 protein products in breast cancer patients

Citation
H. Niewiadomska et al., Immunohistochemical analysis of expression of a 65 kDa oncofetal protein (p65), epidermal growth factor receptor (EGFR), oncogene c-erb B2 and tumor suppressor gene p53 protein products in breast cancer patients, NEOPLASMA, 47(1), 2000, pp. 8-14
Citations number
32
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
NEOPLASMA
ISSN journal
00282685 → ACNP
Volume
47
Issue
1
Year of publication
2000
Pages
8 - 14
Database
ISI
SICI code
0028-2685(2000)47:1<8:IAOEOA>2.0.ZU;2-M
Abstract
Paraffin-embedded tissue slides from 88 infiltrating ductal breast carcinom a were examined by immunohistochemistry technique with the use of monoclona l antibody against human p65 antigen and polyclonal antibody against p65-li ke protein present in fetal bovine serum. Immunohistochemical analysis of e xpression of growth Factor receptors (EGFR), protein product of oncogene c- erb B2 as well as protein product of mutated anti-oncogene p53 was also don e. It was established that there is no correlation between p65 and c-erbB2, EGFR or p53 expression. Tn low differentiated tumors (grade III) high p53 index and high EGFR and c-erbB2 expression was connected with low p65 expre ssion, The lack of c-erbB2 and EGFR and low p53 expression was combined usu ally with high p65 oncoproteine levels.